Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2006 1
2007 1
2008 1
2009 2
2011 7
2012 7
2013 5
2014 1
2015 8
2016 1
2017 3
2018 3
2019 9
2020 1
2021 2
2022 1
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Highly Attenuated Poxvirus-Based Vaccines Against Emerging Viral Diseases.
Perdiguero B, Pérez P, Marcos-Villar L, Albericio G, Astorgano D, Álvarez E, Sin L, Gómez CE, García-Arriaza J, Esteban M. Perdiguero B, et al. J Mol Biol. 2023 Aug 1;435(15):168173. doi: 10.1016/j.jmb.2023.168173. Epub 2023 Jun 8. J Mol Biol. 2023. PMID: 37301278 Free PMC article. Review.
The evolution of poxvirus vaccines.
Sánchez-Sampedro L, Perdiguero B, Mejías-Pérez E, García-Arriaza J, Di Pilato M, Esteban M. Sánchez-Sampedro L, et al. Among authors: perdiguero b. Viruses. 2015 Apr 7;7(4):1726-803. doi: 10.3390/v7041726. Viruses. 2015. PMID: 25853483 Free PMC article. Review.
Immunogenicity and efficacy of a novel multi-patch SARS-CoV-2/COVID-19 vaccine candidate.
Perdiguero B, Marcos-Villar L, López-Bravo M, Sánchez-Cordón PJ, Zamora C, Valverde JR, Sorzano CÓS, Sin L, Álvarez E, Ramos M, Del Val M, Esteban M, Gómez CE. Perdiguero B, et al. Front Immunol. 2023 Jun 19;14:1160065. doi: 10.3389/fimmu.2023.1160065. eCollection 2023. Front Immunol. 2023. PMID: 37404819 Free PMC article.
Clinical applications of attenuated MVA poxvirus strain.
Gómez CE, Perdiguero B, García-Arriaza J, Esteban M. Gómez CE, et al. Among authors: perdiguero b. Expert Rev Vaccines. 2013 Dec;12(12):1395-416. doi: 10.1586/14760584.2013.845531. Epub 2013 Oct 30. Expert Rev Vaccines. 2013. PMID: 24168097 Review.
Potency and durability of T and B cell immune responses after homologous and heterologous vector delivery of a trimer-stabilized, membrane-displayed HIV-1 clade ConC Env protein.
Perdiguero B, Hauser A, Gómez CE, Peterhoff D, Sideris E, Sorzano CÓS, Wilmschen S, Schaber M, Stengel L, Asbach B, Ding S, Von Laer D, Levy Y, Pantaleo G, Kimpel J, Esteban M, Wagner R. Perdiguero B, et al. Front Immunol. 2023 Nov 17;14:1270908. doi: 10.3389/fimmu.2023.1270908. eCollection 2023. Front Immunol. 2023. PMID: 38045703 Free PMC article.
An MVA-based vector expressing cell-free ISG15 increases IFN-I production and improves HIV-1-specific CD8 T cell immune responses.
Falqui M, Perdiguero B, Coloma R, Albert M, Marcos-Villar L, McGrail JP, Sorzano CÓS, Esteban M, Gómez CE, Guerra S. Falqui M, et al. Among authors: perdiguero b. Front Cell Infect Microbiol. 2023 May 29;13:1187193. doi: 10.3389/fcimb.2023.1187193. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37313341 Free PMC article.
58 results